• GSK-923295: A Strategic Probe of Mitotic Fidelity

  2026-09-04

  GSK-923295 offers translational researchers a chemically defined way to interrogate CENP-E motor function, chromosome alignment, and mitotic fidelity. By integrating CENP-E inhibition with emerging evidence on CTCF-dependent centromere architecture, this article outlines a practical framework for mechanistic studies, cancer research, and preclinical decision-making.

• Cholesterol for mRNA-LNP Membrane Research

  2026-09-04

  Learn how Cholesterol B1702 can improve the interpretability of lipid nanoparticle, membrane fluidity, and lipid metabolism experiments. This workflow translates localized p21 mRNA-LNP findings into practical formulation, assay-design, and troubleshooting decisions without overstating what the reference study directly demonstrated.

• Oligo (dT) 25 Beads: Practical mRNA Workflow

  2026-09-03

  Oligo (dT) 25 Beads support selective capture of polyadenylated eukaryotic mRNA from total RNA or animal and plant cell or tissue samples. They are appropriate for polyA-selected mRNA workflows, but not as a general substitute for total RNA purification or for samples dominated by non-polyadenylated or prokaryotic RNA.

• Liproxstatin-1 and the Next Ferroptosis Frontier

  2026-09-03

  Ferroptosis research is moving from redox initiation toward the plasma-membrane events that determine cell rupture. This thought-leadership guide positions Liproxstatin-1 as a mechanistic ferroptosis inhibitor for separating lipid-peroxide accumulation from membrane execution, while outlining translational strategies for renal injury and immuno-oncology models.

• Kupffer Cell Plasticity in Liver Metastasis

  2026-09-02

  This study shows that liver metastasis-associated macrophages are maintained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing and multiomic design clarifies why blocking monocyte-derived macrophages alone may produce limited remodeling of the immunosuppressive metastatic niche.

• MAPK10–KRT16 Signaling Suppresses NSCLC Metastasis

  2026-09-02

  The reference study identifies a phosphorylation-dependent MAPK10/KRT16/RNF213 pathway that limits non-small cell lung cancer metastasis by promoting KRT16 ubiquitination and proteasomal degradation. Its integrated cellular, animal, and clinical evidence supports a mechanistic model for biomarker development while indicating that pathway-specific validation remains necessary before therapeutic translation.

• MK-5108 (VX-689): From AURKA Biology to Assays

  2026-09-01

  MK-5108, also known as VX-689, is a highly selective Aurora A kinase inhibitor for cancer research. This article connects its biochemical selectivity with retinoblastoma evidence and shows how to design more informative cell and xenograft studies without overstating translational conclusions.

• AMG 9810 at the Metabolism–Pain Interface

  2026-09-01

  TRPV1 biology is usually framed through capsaicin, heat, protons, and sensory neuron excitability. A 2024 Autophagy study adds a strategic dimension: metabolic and lysosomal stress can reorganize AMPK–SQSTM1/p62–NFE2L2 signaling through feedback, redox, pH, and calcium-dependent mechanisms. This article explains how AMG 9810 can help translational researchers separate TRPV1-driven sensory signals from stress-adaptive cellular states, while defining the evidence boundaries between pain mechanism research and cancer metabolism.

• 2X Taq PCR Master Mix: From Sample to Symbiont

  2026-08-31

  Learn how 2X Taq PCR Master Mix supports defensible genotyping, cloning, and fungal-symbiont screening. This article connects PCR chemistry with sampling bias, biological validation, and practical assay design.

• Cholecystokinin Octapeptide Ammonium in B-Cell Assays

  2026-08-31

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) is a sulfated brain–gut peptide with receptor-selective immunomodulatory effects. This article translates the key B-cell evidence into an assay-design framework that separates receptor mechanism, cellular state, and endpoint interpretation.

• Ibuprofen Workflows for Cell and COX Assays

  2026-08-30

  Build more informative Ibuprofen experiments by pairing dual COX inhibition with orthogonal proliferation, apoptosis, and cell-cycle readouts. This workflow also adapts protein-binding concepts from a mubritinib–albumin study without assuming that its findings automatically apply to Ibuprofen.

• Acetylspiramycin in the Resistance Era

  2026-08-29

  Acetylspiramycin, also known as Spiramycin B, is more than a conventional macrolide comparator. Its ribosomal mechanism, activity profile in resistant Mycoplasma pneumoniae isolates, and reported immunomodulatory effects position it as a useful bridge between antimicrobial resistance research and host-pathogen biology. This article outlines how translational teams can deploy the compound in susceptibility testing, mechanistic assays, and decision-oriented research while avoiding overinterpretation of in vitro findings.

• From Superoxide Signal to OA Translation

  2026-08-28

  A mechanistic and strategic guide to using DHE-based intracellular superoxide measurement to validate the PQQ–Nrf2–IGF1R axis in age-related osteoarthritis research and strengthen translational decision-making.

• Allosteric PDK4 Inhibitors for Metabolic Disease

  2026-08-28

  Jeon and colleagues developed a new anthraquinone-derived series of allosteric pyruvate dehydrogenase kinase 4 inhibitors, identifying compound 8c as a potent biochemical inhibitor with activity in metabolic, allergic, and cancer-related preclinical models. The study combines medicinal chemistry, enzyme inhibition, metabolic and pharmacokinetic profiling, animal efficacy testing, and molecular docking to support PDK4 as a tractable therapeutic target while highlighting the evidence still needed for translation.

• 3-Deazaneplanocin (DZNep) Assay Guide

  2026-08-27

  A scenario-based guide to using 3-Deazaneplanocin (DZNep), SKU A1905, in viability, proliferation, apoptosis, and cancer stem cell assays. It connects formulation data, concentration and exposure choices, orthogonal readouts, and vendor-selection criteria to improve interpretation and experimental consistency.

8084 records 1/539 page Next 12345 下5页 Last page